Related Experiment Video
Updated: Aug 8, 2026
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Newborn screening: toward a uniform screening panel and system--executive summary
Insights
Standardizing newborn screening programs is crucial for early detection of genetic disorders. A recommended uniform panel of 29 mandated conditions and 25 additional conditions will improve infant health outcomes.
Area of Science:
- Medical Genetics
- Public Health
- Pediatrics
Background:
- State newborn screening programs lack standardized outcomes and guidelines.
- There is a need to define responsibilities for collecting and evaluating outcome data.
- A uniform panel of conditions for newborn screening is recommended.
Purpose of the Study:
- To outline a standardization process for state newborn screening programs.
- To define responsibilities for collecting and evaluating outcome data.
- To recommend a uniform panel of conditions for state newborn screening.
Main Methods:
- Commissioned an expert panel from the American College of Medical Genetics.
- Identified conditions based on mandated screening, differential diagnosis, clinical significance, and incidental findings.
- Described the identification process and provided recommendations.
Main Results:
- Identified 29 conditions for mandated newborn screening.
- Identified an additional 25 conditions for consideration.
- These additional conditions include those in the differential diagnosis, clinically significant findings without treatment, and incidental findings.
Conclusions:
- A standardized approach to newborn screening is essential.
- The recommended panel aims to improve early detection and management of genetic disorders.
- Clear guidelines and responsibilities for data collection and evaluation are provided.
Abstract:
The Maternal and Child Health Bureau commissioned the American College of Medical Genetics to outline a process of standardization of outcomes and guidelines for state newborn screening programs and to define responsibilities for collecting and evaluating outcome data, including a recommended uniform panel of conditions to include in state newborn screening programs. The expert panel identified 29 conditions for which screening should be mandated. An additional 25 conditions were identified because they are part of the differential diagnosis of a condition in the core panel, they are clinically significant and revealed with screening technology but lack an efficacious treatment, or they represent incidental findings for which there is potential clinical significance. The process of identification is described, and recommendations are provided.
